Ambu A/S: Capital increase in connection with exercise of warrants issued
05. Februar 2021 05:42 ET
|
Ambu A/S
Capital increase in connection with exercise of warrants Ambu A/S issued 770,000 warrants in 2015 and 419,500 warrants in November 2016. Each warrant entitles the holder to subscribe for one Class B...
Registration of share capital increase of 4,711,832 new B shares completed
01. Februar 2021 02:48 ET
|
Ambu A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR IN ANY...
Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities
29. Januar 2021 07:31 ET
|
Ambu A/S
In accordance with its long-term incentive program ("LTIP") Ambu A/S has allocated performance share units (PSUs) to members of the Executive Board. Reference is made to the company announcement of 29...
Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities
29. Januar 2021 07:30 ET
|
Ambu A/S
In accordance with its long-term incentive program ("LTIP") Ambu A/S has allocated performance share units (PSUs) to members of the Executive Board. Reference is made to the company announcement of 29...
Launch of Long-Term Incentive Plan
29. Januar 2021 07:24 ET
|
Ambu A/S
In accordance with the Remuneration Policy approved at the annual general meeting on 17 December 2019, Ambu A/S has today launched a long-term incentive plan for the Executive Board. In addition, 186...
Completion of accelerated bookbuild offering
28. Januar 2021 01:36 ET
|
Ambu A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR IN ANY...
Status on accelerated bookbuild offering – Priced at DKK 262 per B share
27. Januar 2021 17:52 ET
|
Ambu A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR IN ANY...
Interim report for Q1 2020/21
27. Januar 2021 01:59 ET
|
Ambu A/S
Ambu delivered organic revenue growth of 39% in Q1. The demand for single-use endoscopes is positively influenced by COVID-19. Commercial launch of aScope™ Duodeno is on track, and clinical trial has...
Ambu A/S seeks to strengthen its capital base
27. Januar 2021 01:57 ET
|
Ambu A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR IN ANY...
Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities
09. Dezember 2020 10:25 ET
|
Ambu A/S
Please see attached file.
Attachment
09_12_2020 Jørgen Falkebo Jensen
...